SCHEMBL8052277

SCHEMBL8052277

COC(=O)CN1CCC(N2CCN(c3ccc(C#N)cc3)C(=O)C2)CC1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 8/20 0.44
CYP2D6 P10635 2/20 0.44
KCNH2 Q12809 2/20 0.44
HRH1 P35367 1/20 0.41
ALK Q9UM73 1/20 0.41
USP14 P54578 3/20 0.40
AR P10275 1/20 0.40
USP5 P45974 1/20 0.40
USP7 Q93009 1/20 0.40
FNTA P49354 1/20 0.38
FNTB P49356 1/20 0.38
PGGT1B P53609 1/20 0.38
POLB P06746 1/20 0.36
ITGB3 P05106 1/20 0.36
ITGA2B P08514 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8043231 0.90 HRH3 (0.43) HRH3CYP2D6KCNH2HRH1ALK
SCHEMBL8034797 0.82 ITGB3 (0.44) HRH3KCNH2HRH1ITGB3ITGA2B
Hydrochloric Acid SCHEMBL8043473 0.82 ALOX15 (0.58) HRH3KCNH2HRH1ITGB3ITGA2B
SCHEMBL8034391 0.81 ITGB3 (0.43) HRH3KCNH2HRH1ITGB3ITGA2B
SCHEMBL8686413 0.77 MEN1 (0.43) HRH3CYP2D6HRH1USP14USP5
SCHEMBL9171577 0.76 POLB (0.59) POLB
SCHEMBL7344717 0.75 ITGB3 (0.47) HRH3USP14ARUSP5USP7
SCHEMBL8043708 0.74 ITGB3 (0.41) HRH3KCNH2POLBITGB3ITGA2B
SCHEMBL8044034 0.74 ITGB3 (0.42) HRH3KCNH2HRH1POLBITGB3
SCHEMBL8044020 0.73 ITGB3 (0.55) HRH3ITGB3ITGA2BALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6057324-A HAVE GPIIB/IIIA RECEPTOR ANTAGONIZING ACTIVITY AND ARE USEFUL FOR AMELIORATING ISCHEMIC CARDIAC DISORDERS, FOR AMELIORATING CEREBROVASCULAR DISORDERS, AND FOR AMELIORATING PERIPHERAL ARTERY DISORDERS YAMANOUCHI PHARMACEUTICAL CO., LTD (JP) 2000-05-02 US disclosed
EP-0905129-A1 SUBSTITUTED AMIDINOBENZENE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1999-03-31 EP disclosed